Atlas Trials

Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests

Clinical trial NCT05995808 · UNKNOWN

Trial details

NCT number
NCT05995808
Sponsor
Sohag University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2023-09-01
Primary completion
2024-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.